HuGE Literature Finder
Records
1
-
6
TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World journal of gastrointestinal oncology 2019 Jul 11 (7): 551-566. Ntavatzikos Anastasios, Spathis Aris, Patapis Paul, Machairas Nikolaos, Vourli Georgia, Peros George, Papadopoulos Iordanis, Panayiotides Ioannis, Koumarianou An |
Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer. Oncology letters 2019 Jun 17 (6): 5469-5480. Zhu Lizhe, Ma Nan, Wang Bin, Zhou Can, Yan Yu, Wang Ke, He Jianjun, Ren |
Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis. Clinics and research in hepatology and gastroenterology 2016 Dec . Wang X, Sun X, Du X, Zhou F, Yang F, Xing J, Dong G, Guo |
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Apr . Dong Honglin, Bao Dengke, Guo Xu, Hu Jie, Li Xiaofei, Wan Shaogui, Xing Jinlia |
Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Mar 29 (7): 875-83. Tan Benjamin R, Thomas Fabienne, Myerson Robert J, Zehnbauer Barbara, Trinkaus Kathryn, Malyapa Robert S, Mutch Matthew G, Abbey Elliot E, Alyasiry Amer, Fleshman James W, McLeod Howard |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: